COLL Q1 2017 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena

COLLCollegium Pharmaceutical, Inc.

$1B

Q1 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2M

Gross Profit

$2M82.9% margin

Operating Income

-$23M-1067.0% margin

Net Income

-$23M-1062.5% margin

EPS (Diluted)

$-0.79

QoQ Revenue Growth

+66.7%

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$24M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$140M

Total Liabilities

$25M

Stockholders' Equity

$114M

Cash & Equivalents

$130M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$0	—
Gross Profit	$2M	$0	—
Operating Income	-$23M	-$16M	-48.7%
Net Income	-$23M	-$16M	-47.4%